Fibrobiologics, INC Form 4 insider transactions

FibroBiologics CEO Pete O'Heeron acquired 8,500 shares of the company's common stock at an average price of $1.914 on August 12, 2024.

Hamid Khoja, Chief Scientific Officer of FibroBiologics, Inc. (FBLG), reported the acquisition and disposal of common stock on August 12, 2024.

Ruben A. Garcia, General Counsel of FibroBiologics, Inc., was granted options to purchase 180,000 shares of common stock on March 1, 2024.